Last reviewed · How we verify
NCT06958848
16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy
NA trial testing 16 F chest tube in Pneumothorax in 124 participants. Currently enrolling.
30 April 2027
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 124 |
| Start date | 1 May 2025 |
| Primary completion | 30 April 2027 |
| Estimated completion | 30 August 2027 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- 16 F chest tube
- 24 F chest tube
- Early removal
- Standard removal
Conditions studied
- Pneumothorax — all drugs for Pneumothorax →
- Pleural Effusion — all drugs for Pleural Effusion →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 80, any sex, with Pneumothorax or Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06958848
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumothorax
Currently open trials in the same condition.
- NCT07344714 — Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting · recruiting
- NCT06340178 — CT-guided Lung Biopsy Risk Optimization Method · NA · recruiting
- NCT06983366 — Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases · recruiting
- NCT07211529 — Intraoperative Paravertebral Block and Postoperative Complications · NA · recruiting
- NCT00033137 — Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06958848 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06958848.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing